Abstract
Although gefitinib, a selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, has been demonstrated to exhibit its antitumor activity by the blockade of EGF receptor, the role of signaling pathways downstream of EGFR in gefitinib sensitivity remains unknown. In this study, we investigated the mechanistic role of Src and Ras, major oncogene products implicated in the pathogenesis of many human cancers in gefitinib sensitivity. Using parental and v-src- or c-H-ras-transfected HAG-1 human gallbladder adenocarcinoma cell lines, effects of gefitinib on cytotoxicity, cell cycle purtubation and apoptosis, and tyrosine phosphorylation of EGFR, Akt, and Erk were determined by WST-1 assay, flow cytometry, and Western blots, respectively. Activated Ras and Src conferred a strong resistance to gefitinib by nearly 30-fold and 200-fold, respectively. Gefitinib induced accumulation of cells in the G0/G1 phase of the cell cycle at 24-h, with progressive expansion of apoptotic cell population in parental HAG-1 cells, but these effects were completely abolished in v-src- or c-H-ras-transfected cell line. Upon gefitinib treatment, EGFR activation and subsequent downstream activation through Erk and Akt were significantly i...Continue Reading
References
Jan 1, 1987·Annual Review of Cell Biology·R Jove, H Hanafusa
Oct 24, 1995·Biochemical and Biophysical Research Communications·K SatoY Fukami
Jul 1, 1995·Critical Reviews in Oncology/hematology·D S SalomonN Normanno
Apr 10, 1995·International Journal of Cancer. Journal International Du Cancer·T TatsumotoY Niho
Nov 1, 1994·In Vitro Cellular & Developmental Biology. Animal·S NakanoY Niho
Sep 1, 1994·Human Pathology·S Valerdiz-Casasola
Jan 1, 1993·Human Pathology·M YukawaK Nagasako
Apr 1, 1996·Current Opinion in Cell Biology·R Treisman
Nov 1, 1995·Pathology, Research and Practice·C S Lee, A Pirdas
Jun 23, 1997·FEBS Letters·I Alroy, Y Yarden
Jan 28, 1998·Oncogene·W MaoT J Yeatman
Apr 3, 1998·Journal of Cellular Physiology·Y MurakamiK Izuhara
May 19, 1998·Molecular Carcinogenesis·J S BiscardiS J Parsons
Jun 13, 1998·Journal of the National Cancer Institute·J Rubin GrandisD J Tweardy
Aug 26, 1998·Molecular and Cellular Biology·M A OlayioyeN E Hynes
Sep 3, 1998·The Journal of Biological Chemistry·J YanJ F Hancock
Sep 22, 1999·Molecular and Cellular Biology·S K MuthuswamyJ S Brugge
Nov 1, 2000·Cell·J Schlessinger
Dec 15, 2000·Oncogene·R B Irby, T J Yeatman
Oct 5, 2001·Cellular Signalling·C Liebmann
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·N G AndersonN J Bundred
May 3, 2002·British Journal of Cancer·N MagnéG Milano
Mar 20, 2003·Seminars in Oncology·Francis M Sirotnak
May 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Masahiro FukuokaJosé Baselga
May 1, 2004·The New England Journal of Medicine·Thomas J LynchDaniel A Haber
May 1, 2004·Science·J Guillermo PaezMatthew Meyerson
Jul 31, 2004·Science·Raffaella SordellaJeffrey Settleman
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Sae-Won HanNoe Kyeong Kim
Jul 9, 2005·International Journal of Cancer. Journal International Du Cancer·Maarten L JanmaatGiuseppe Giaccone
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Miguel TaronTeresa Moran
Citations
May 22, 2008·Investigational New Drugs·Xishan XiongChanglin Mei
Jan 14, 2009·Investigational New Drugs·Xishan XiongChanglin Mei
Dec 14, 2011·Nature Medicine·Michela GarofaloCarlo M Croce
Apr 5, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G Giaccone, P A Zucali
May 10, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P A ZucaliG Giaccone
Mar 14, 2007·Anti-cancer Drugs·Ami N Shah, Gary E Gallick
Jun 12, 2008·Molecular Pharmacology·Aditi Pandya MartinPaul Dent
Jan 2, 2009·Cancer Research·Nathan T IhleGarth Powis
Apr 9, 2009·Cancer Research·Elizabeth Peterson-RothPeter M Glazer
Oct 29, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nicolas GirardWilliam Pao
Dec 22, 2011·Molecular Cancer·Debora D MeiraCarlos G Ferreira
Oct 3, 2012·PloS One·Stephanie N Shishido, Thu A Nguyen
Nov 13, 2010·Thoracic Surgery Clinics·Nicolas Girard
Oct 1, 2010·Surgical Oncology·Sanjeev K MauryaHari S Shukla
Feb 2, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Robert L KeithYork E Miller
Aug 22, 2012·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Zhi XiaoLili Tang
Oct 7, 2009·Cancer Science·Takeshi YoshidaKazuhiko Nakagawa
Jun 4, 2013·Biochemical and Biophysical Research Communications·Misaki OnoShuji Nakano
Mar 19, 2014·PloS One·Weiling ZhengZhiyuan Gong
Apr 5, 2013·PloS One·Hye-Lim JuSimon Weonsang Ro
Jan 1, 2014·PloS One·Ingrid MarcqHicham Bouhlal
Oct 25, 2016·Oncogene·A Dokala, S S Thakur
Nov 9, 2016·Oncotarget·Maolan LiWei Gong
Mar 8, 2018·Molecular Medicine Reports·Lei ZhangLin Wang
Aug 30, 2017·Oncology Reports·Yan LiJindong Chen
Sep 30, 2020·Cell Death and Differentiation·Sang-Hyun LeeJeong-Ki Min
Aug 14, 2013·ChemMedChem·Brendan FrettHong-Yu Li
Apr 22, 2015·Oncotarget·Yinghe QiuChangqing Su
Jul 25, 2020·Nutrition and Cancer·Misaki OnoShuji Nakano
Feb 18, 2010·Molecular Cancer Therapeutics·Elisa GiovannettiCarmelo Tibaldi